Clinical Trial Update: Study of AK112 in the Treatment of Advanced Gynecological Tumors [Phase 2]

View source ↗

Summary

Phase 2 study of AK112 for advanced gynecologic tumors has been completed, evaluating efficacy in ovarian, cervical, and endometrial cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• AK112

Snippet

Sponsor: Akeso | Conditions: Gynecologic Cancer, Cancer Metastatic | Phase 2 | Status: COMPLETED